Glenmark Life Sciences (GLS.NSE) Q3 2024 Earnings

Jul 25Confirmed
Q1 2024
Q3 2024
8
9.55
11.1
12.64

Details

Expected EPS
9.789892769475
Actual EPS
8.93641493829
Surprise EPS
-0.85
Surprise Percent
-8.72%

Description

⁨Glenmark Life Sciences⁩ (⁦GLS.NSE⁩) has reported earnings of ⁦8.93641493829⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts